Abstract
For many years, there has been considerable interest in the chemistry and pharmacology of biological transmethylation in the field of neurophsychiatry. This interest was largely stimulated by the fact that many of the natural or synthetic substances which produce hallucinations or other features of psychotic illness are methylated amines — see (5). As early as 1952, Osmond and Smythies reported (73) a suggestion of the biochemist Har-ley-Mason that abnormal transmethylation of an endogenous amine, possibly dopamine, might produce a psychotomimetic compound like mescaline (3, 4, 5-trimethoxyphenyl-ethylamine). More direct evidence consistent with this hypothesis was the observation that methionine, uniquely among several amino acids, and especially when combined with an inhibitor or monoamine oxidase, led to striking but transient exacerbations of the psychotic symptoms of chronic schizophrenic patients (75). This clinical phenomenon is unique among biochemical findings in schizophrenia in that it has been confirmed by several groups and so far contradicted by none (1, 2,15, 21, 41, 49, 74, 86; see also 27, 29).
Based in part on material presented previously in: Baldessarini, R.J.: Biological transmethylation involving S-adenosylmethionine: Development of assays and implications for neuropsychiatry. Int. Rev. Neurobiol. 18, 41 (1945); and Baldessarini, R.J.: Sviluppo ed applicazione dei metodi per la determinazione delle transmetilazioni biologiche S-S-adenosilmetionina dipendenti; in: Transmetilazioni e Sistema Nervoso Centrale, Edi-zioni Minerva Medica, Roma, 1976, p. 51.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander, F., Curtis, G.C., Sprince, H., Crosley, A.P.: L-methionine and L-trypto-phan feedings in non-psychotic and schizophrenic patients with and without tranylcypromine. J. nerv. Dis. 137, 135 (1963)
Antun, F.T., Burnett, G.B., Cooper, A.J., Daly, R.J., Smythies, J.R., Zealley, A.K.: Effects of L-methionine (without MAOI) in schizophrenia. J. psychiat. Res. 8, 63 (1971)
Antun, F., Eccleston, D., Smythies, J.R.: Transmethylation process in schizophrenia. In: Brain Chemistry and Mental Disease, Ho, B.T., Mclsaac, W.M. (eds.) New York: Plenum, pp. 61–71
Axelrod, J., Cohn, C.K.: Methyltransferase enzymes in red blood cells. J. Pharmacol. exp. Ther. 176, 650 (1971)
Baldessarini, R.J.: Factors influencing S-adenosylmethionine levels in mammalian tissues. In: Amines and Schizophrenia, Himwich, H., Kety, S., Smythies, J. (eds.) Oxford: Pergamon 1966, p. 199
Baldessarini, R.J.: Alterations in tissue levels of S-adenosylmethionine. Biochem. Pharmacol. 15, 741 (1966)
Baldessarini, R.J.: Biogenic amine hypotheses in affective disorders. In: The Nature and Treatment of Depression, Draghi, S.C., Flach, F.F. (eds.) New York: Wiley, 1975. Chap. 9, p. 347
Baldessarini, R.J., Bell, W.R.: Methionine-activating enzyme and catechol-O-methyl-transferase activity in normal and leukemic white blood cells. Nature (Lond.) 209, 78 (1966)
Baldessarini, R.J., Carbone, P.P.: Adenosylmethionine elevation in leukemic white blood cells. Science 149, 644 (1965)
Baldessarini, R.J., Fischer, J.E.: S-adenosylmethionine following portacaval anastomoses. Surgery 62, 311 (1967)
Baldessarini, R.J., Greiner, E.: Inhibition of catechol-O-methyl transferase by catechols and polyphenols. Biochem. Pharmacol. 22, 247 (1973)
Baldessarini, R.J., Karobath, M.: Effects of L-dopa and L-3-O-methyl-dopa on uptake of [3H]-L-methionine by synaptosomes. Neuropharmacology 11, 715 (1972)
Baldessarini, R.J., Kopin, I.J.: Assay of tissue levels of S-adenosylmethionine. Analyt. Biochem. 6, 289 (1963)
Baldessarini, R.J., Kopin, I.J.: S-adenosylmethionine in brain and other tissues. J. Neurochem. 13, 769 (1966)
Ban, T.A.: On-going national collaborative studies in Canada: Niacin in the treatment of schizophrenics. Psychopharmacol. Bull. 5, 5 (1969)
Banerjee, S.P., Snyder, S.H.: Methyltetrahydrofolic acid mediates N- and O-methyla-tion of biogenic amines. Science 182, 74 (1973)
Barchas, J.D., Elliott, G.R., DoAmaral, J., Erdelyi, E., O’Connor, S., Bowden, M., Brodie, H., Berger, P., Renson, J., Wyatt, R.J.: Tryptolines: Formation from trypt-amines and 5-MTHF by human platelets. Arch. Gen. Psychiat. 31, 862 (1974)
Bartholini, G., Pletscher, A.: Distribution and metabolism of L-3-O-methyl-Dopa in rats. Brit. J. Pharmacol. Chemother. 40, 461 (1970)
Baudry, M., Chast, F., Schwartz, J.-C: Studies on S-adenosyl-homocysteine inhibition of histamine transmethylation in brain. J. Neurochem. 20, 13 (1973)
Berlet, H.H., Matsumoto, K., Pschedit, G.R., Spaide, J., Bull, C, Himwich, H.E.: Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor. Arch. gen. Psychiat. 13, 521 (1965)
Brune, G.G., Himwich, H.E.: Effects of methionine-loading on the behavior of schizophrenic patients. J. nerv. ment. Dis. 134, 447 (1962)
Brune, G.G., Himwich, H.E.: Biogenic amines and behavior in schizophrenic patients. In: Recent Advances in Biological Psychiatry. Wortis, J. (ed.) New York: Plenum 1963, Vol. V, p. 144
Buscaino, G.A., Spadetta, V., Carella, A.: II test di metilazione nella schizofrenia, Acta neurol. (Napoli) 24, 113 (1969)
Cantoni, G.L.: Methylation of nicotinamide with a soluble enzyme system from rat liver. J. biol. Chem. 189, 203 (1951)
Carey, M.C., Donovan, D.E., Fitzgerald, O., McCauley, F.D.: Homocystinuria — I. A clinical and pathological study of nine subjects in six families. Amer. J. Med. 45, 7 (1968)
Chalmers, J.P., Baldessarini, R.J., Wurtman, R.J.: Effects of L-dopa on norepinephrine metabolism in the brain. Proc. nat. Acad. Sci. (Wash.) 68, 662 (1971)
Cohen, S.M., Nichols, A., Wyatt, R., Pollin, W.: The administration of methionine to chronic schizophrenic patients: a review of ten studies. Biol. Psychiat. 8, 209 (1974)
Cohn, CK., Dunner, D.L., Axelrod, J.: Reduced catechol-O-methyl transferase activity in red blood cells of women with primary affective disorders. Science 170, 1323 (1970)
Coper, H., Deyhle, G., Fähndrich, C, Fähndrich, E., Rosenberg, L. Strauss, S., Blum, A., Dufour, H.: Excretion of vanillyl-mandelic acid, homovanillic acid, N-methyl-nicotinamide and N-methyl-2-pyridone-5-carboxamide in urine of voluntary test persons and psychiatric patients before and after administration of methionine. Phar-makopsychiat. Neuropsychopharmakol. 5, 177 (1972)
Creveling, CR., Daly, J.W.: Identification of 3,4-dimethoxy-phenethylamine from schizophrenic urine by mass spectrometry. Nature (Lond.) 216, 190 (1967)
Deguchi, T., Barchas, J.: Inhibition of transmethylations of biogenic amines by S-adenosylhomocysteine. J. biol. Chem. 246, 3175 (1971)
Domino, E.F., Krause, R.R., Bowers, J.: Various enzymes involved with putative neurotransmitters. Arch. gen. Psychiat. 29, 195 (1973)
Donaldson, K.O., Keresztesy, J.C.: Further evidence on the nature of prefolic A. Biochem. biophys. Res. Commun. 5, 289 (1961)
Dunner, D.L., Cohn, CK., Weinshilboum, R.M., Wyatt, R.J.: The activity of dopamines-hydroxylase and methionine-activating enzyme in blood of schizophrenic patients. Biol. Psychiat. 6, 215 (1973)
Fazio, C, Andreoli, V., Agnoli, A., Casacchia, M., Cerbo, R.: Effetti terapeutici della S-adenosil-metionina (SAMe) nelle sindromi depressive. Minerva med. (Roma) 64, 1515 (1973)
Fischer, E., Spatz, H.: Studies on urinary elimination of bufotenine-like substances in schizophrenia. Biol. Psychiat. 2, 235 (1970)
Friedhoff, A.J., Winkle, Van: Characteristics of an amine found in urine of schizophrenic patients. J. nerv. men. Dis. 135, 550 (1962)
Gillin, J.C., Cannon, E., Magyar, R., Schwartz, M., Wyatt, R.J.: Failure of N, N-di-methyltryptamine to evoke tolerance in cats. Biol. Psychiat. 7, 213 (1973)
Hall, P., Hartridge, G., Leeuwen, G.H. van: Effect of catechol-O-methyltransferase in schizophrenia. Arch. gen. Psychiat. 20, 573 (1969)
Hartley, R., Padwick, D., Smith, J.A.: The inhibition of pineal hydroxyindole-O-methyltransferase by haloperidol and fluphenazine. J. Pharm. (Lond.) 24 (Suppl.), 100 (1972)
Haydu, G.G., Dhrymiotis, A., Korenyl, C, Goldschmidt, L.: Effects of methionine and hydroxychloroquine in schizophrenia. Amer. J. Psychiat. 122, 560 (1965)
Heath, R.G., Nesselhof, W., Jr., Timmons, E.: D, L-methionine-d, 1, -sulfoximine effects in schizophrenic patients. Arch. gen. Psychiat. 14, 213 (1966)
Heslinga, F.J.M., Tilburg, W. van, Stam, F.C.: The identity of the so-called pink spot in schizophrenia and Parkinson’s disease. Psychiat. Neurol. Neurochir. (Amst.) 73, 157 (1970)
Hoffer, A., Osmond, H.: Treatment of schizophrenia with nicotinic acid: a ten-year follow-up. Acta psychiat. scand. 40, 171 (1964)
Horwitt, M.K., Harvey, C.C, Rothwell, W.S., Cutter, J.L., Hoffron, D.: Tryptophan-niacin relationship in man. J. Nutr. 60 (Suppl.), 1 (1956)
Hsu, L.L., Mandell, A.J.: Multiple N-methyltransferases for aromatic alkylamines in brain. Life Sci. 13, 847 (1973)
Hsu, L.L., Mandell, A.J.: Enzymatic formation of tetrahydro-13-carboline from trypt-amine and 5-methyltetrahydrofolic acid in rat brain fractions: regional and subcellular distribution. J. Neurochem. 24, 631 (1975)
Israelstam, D.M., Sargent, T., Finley, N.N., Winchell, H.S., Fish, M.B., Motto, J., Pollycove, M., Johnson, A.: Abnormal methionine metabolism in schizophrenic and depressive states. J. psychiat. Res. 7, 185 (1970)
Kakimoto, Y., Sano, I., Kanazawa, A., Tsujio, T., Kaneko, Z.: Metabolic effects of methionine in schizophrenic patients pretreated with a monoamine oxidase inhibitor. Nature (Lond.) 216, 1110 (1967)
Kopin, I.J., Baldessarini, R.J.: Assay of tissue levels of S-adenosylmethionine. In: Methods in Enzymology, Vol. 17B: Metabolism of amino acids and amines. Tabor, H., Tabor, C.W. (eds.) New York: Academic Press, 1971, p. 397
Korevaar, W.C, Geyer, M.A., Knapp, S., Hsu, L.L., Mandell, A.J.: Regional distribution of 5-methyl-tetrahydrofolic acid in brain. Nature New Biol. 245, 244 (1973)
Laduron, R.: N-methylation of dopamine to epinine in brain tissue using N-methyl-tetrahydrofolic acid as the methyl donor. Nature New Biol. 238, 212 (1972)
Laduron, P.M., Gommersen, W.R., Leysen, J.E.: N-methylation of biogenic amines. Biochem. Pharmacol. 23, 1599 (1974)
Lin, R.-L., Narasimhachari, N., Himwich, H.E.: Inhibition of indolethylamine-N-methyltransferase by S-adenosylhomocysteine. Biochem. biophys. Res. Commun. 54,751 (1973)
Lin, R.-L., Narasimhachari, N.: Evidence for the absence of amine-N-methylation and O-methylation in indolethylamines with methyltetrahydrofolic acid-dependent N-methyltransferase. Res. Commun, ehem. Path. Pharmacol. 8, 535 (1974)
Lipinski, J.F., Schaumburg, H.H., Baldessarini, R.J.: Regional distribution of histamine in human brain. Brain Res. 52, 403 (1973)
Lipinski, J.F., Mandel, L.R., Ahn, H.S., Heuvel, W.J.A. van den, Walker, R.W.: Blood dimethyltryptamine concentrations in psychotic disorders. Biol. Psychiat. 9, 89 (1974)
Lipton, M.A. (ed.): Megavitamin and orthomolecular therapy in psychiatry. American Psychiatric Association Task Force Report No. 7, Washington, D.C., 1973, pp. 54
Lombardini, J.B., Burch, M.K., Talalay, P.: An enzymatic derivative double-isotope assay for L-methionine. J. biol. Chem. 246, 4465 (1971)
Mandel, L.R., Walker, R.W., Rosegay, A., Heuvel, W.J.A. van den, Rokach, J.: 5-methyltetrahydrofolic acid as a mediator in the formation of pyridoindoles. Science 186, 741 (1974)
Mandell, A.J., Morgan, M.: Indole (ethyl) amine N-methyltransferase in human brain. Nature New Biol. 230, 85 (1971)
Matthysse, S., Baldessarini, R.J.: S-adenosylmethionine and catechol-O-methyl-transferase in schizophrenia. Amer. J. Psychiat. 128, 1310 (1972)
Matthysse, S., Baldessarini, R.J., Vogt, M.: Methionine adenosyltransferase: a double-isotope derivative, enzymatic assay. Analyt. Biochem. 48, 410 (1972)
Matthysse, S., Lipinski, J., Shih, V.: L-dopa and S-adenosylmethionine. Clin. chim. Acta 35, 253 (1971)
McKensie, R.M., Gholson, R.K.: A simple assay for methionine adenosyltransferase using cation exchange paper and liquid scintillation spectrometry. Analyt. Biochem. 53, 384 (1973)
Meiler, E., Rosengarten, H., Friedhoff, A.J.: Conversion of [Cl4]-S-adenosylmethio-nine to [C14]-formaldehyde and condensation with indoleamines: a side-reaction in N-methyltransferase assay in blood. Life Sci. 14, 2167 (1974)
Melier, E., Rosengarten, H., Friedhoff, A.J.: 5-methyltetrahydrofolic acid is not a methyl donor for biogenic amines: evidence for the enzymatic formation of formaldehyde, Science 187, 171 (1975)
Murphy, D.L.: Mental effects of L-dopa. Ann. Rev. Med. 24, 209 (1973)
Murphy, D.L., Wyatt, R.J.: Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature (Lond.) 238, 225 (1972)
Narasimhachari, N., Himwich, H.E.: GC-MS identification of bufotenin in urine samples from patients with schizophrenia or infantile autism. Life Sci. II 12, 475 (1973)
Narasimhachari, N., Himwich, H.E.: Gas chromatographic-mass spectrometric identification of N, N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring. Biochem. biophys. Res. Commun. 55, 1064 (1973)
Narasimhachari, N., Plaut, J., Himwich, H.E.: 3,4-Dimethoxyphenylethylamine, a normal or abnormal metabolite? J. psychiat. Res. 9, 325 (1972)
Osmond, H., Smythies, J.: Schizophrenia: a new approach. J. ment. Sci. 98, 309 (1952)
Park, L.C., Baldessarini, R.J., Kety, S.S.: Methionine effects in chronic schizophrenics. Arch. gen. Psychiat. 12, 346 (1965)
Pollin, W., Cardon, P.V., Jr., Kety, S.S.: Effects of amino acid feedings in schizophrenic patients treated with iproniazid. Science 133, 104 (1961)
Price, J.: Methylation in schizophrenics: a pharmacogenetic study. J. psychiat. Res. 9, 345 (1972)
Rubin, R.A., Ordonez, L.A., Wurtman, R.J.: Physiological dependence of brain methionine and S-adenosylmethionine concentrations on serum amino acid pattern. J. Neurochem. 23, 227 (1974)
Saavedra, J.M., Coyle, J.T., Axelrod, J.: The distribution and properties of the nonspecific N-methyltransferase in brain. J. Neurochem. 20, 743 (1973)
Salvatore, F., Utili, R., Zappia, V.: Quantitative analysis of S-adenosylmethionine and S-adenosylhomocysteine in animal tissues. Analyt. Biochem. 41, 16 (1971)
Schwartz, M.A., Aikens, A.M., Wyatt, R.J.: Monoamine oxidase activity in brains from schizophrenic and mentally normal individuals. Psychopharmacologia (Berl.) 38, 319 (1974)
Schweitzer, J.W., Friedhoff, A.J., Angrist, B.M., Gershon, S.: Excretion of p-methoxy-amphetamine administered to humans. Nature (Lond.) 229, 133 (1971)
Sharma, S., Sinari, V.P.: Pink spot in the urine and C.S.F. of schizophrenics. Dis. nerv. Syst. 32, 831 (1971)
Simpson, G.M., Varga, V.: An investigation of the clinical effect of GPA-1714, a catechol-O-methyltransferase inhibitor. J. clin. Pharmacol. 12, 417 (1972)
Sloane, K.M., Bridges: The in vitro uptake of [35S]-L-methionine by normal and leukaemic leucocytes. Acta haemat. (Basel) 40, 18 (1968)
Snyder, S.H., Baldessarini, R.J., Axelrod, J.: A sensitive and specific enzymatic iso-topic assay for tissue histamine. J. Pharmacol, exp. Ther. 153, 544 (1966)
Spaide, J., Tanimukai, H., Bueno, J.R., Himwich, H.E.: Behavioral and biochemical alterations in schizophrenic patients. Arch. gen. Psychiat. 18, 658 (1968)
Sprince, H.: An appraisal of methionine-tryptophan interrelationships in mental illness: methylation reactions involved. Biol. Psychiat. 2, 109 (1970)
Sprince, H., Parker, CM., Jameson, D., Elexander, F.: Urinary indoles in schizophrenic and psychoneurotic patients after administration of tranylcypromine (Parnate) and methionine or tryptophan. J. nerv. ment. Dis. 137, 246 (1963)
Tanimukai, H., Ginther, R., Spaide, J., Bueno, J.R., Himwich, H.E.: Detection of psychotomimetic N, N-dimethylated indoleamines in the urine of four schizophrenic patients. Brit. J. Psychiat. 117, 421 (1970)
Taylor, K.M., Snyder, S.H.: Isotopic microassay of histamine, histidine, histidine decarboxylase and histamine methyl transferase in brain tissue. J. Neurochem. 10, 1343 (1972)
Tran-Manh, N., Laplante, M., Saint-Laurent, J., LeBel, E.: Abnormalities in 14CO2 production from D.L-3,4-dihydroxyphenylalanine-[carboxyl-l4C] in schizophrenia and parkinsonism. Rev. canad. Biol. 31 (Suppl.), 255 (1972)
Wurtman, R.J., Rose, CM., Matthysse, S., Stephenson, J., Baldessarini, R.J.: L-di-hydroxyphenylalanine: effect on S-adenosylmethionine in brain. Science 169, 395 (1970)
Wyatt, R.J., Mandel, L.R., Ahn, H.S., Walker, R.W., Heuvel, W.J.A. van den: Gas chromatographic-mass spectrometric isotope dilution determination of N, N-dimethyl-tryptamine concentrations in normals and psychiatric patients. Psychopharmacologia (Berl.) 31, 265 (1973)
Wyatt, R.J., Murphy, D.L., Belmaker, R., Cohen, S., Donnelly, C.H., Pollin, W.: Reduced monoamine oxidase activity in platelets: a possible genetic marker to vulnerability to schizophrenia. Science 179, 916 (1973)
Wyatt, R.J., Saavedra, J.M., Axelrod, J.: A dimethyltryptamine-forming enzyme in human blood. Amer. J. Psychiat. 130, 754 (1973)
Wyatt, R.J., Erdelyi, E., Do Amaral, J.R., Elliott, G.R., Renson, J., Barchas, J.D.: Tetrahydro-?-carboline formation by human platelets and brain from methyltetra-hydrofolic acid and tryptamine. Science. In press (1977)
Yaryura-Tobias, J.A., Merlis, S.: Levodopa and schizophrenia. J. Amer. med. Ass. 211, 1857 (1970)
Zappia, V., Zydek-Cwick, CR., Schlenck, F.: The specificity of S-adenosylmethionine derivatives in methyl transfer reactions. J. biol. Chem. 244, 4499 (1969)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Baldessarini, R.J. (1978). On the Development and Utilization of Assays for Biological Transmethylation Involving S-Adenosylmethionine. In: Andreoli, V.M., Agnoli, A., Fazio, C. (eds) Transmethylations and the Central Nervous System. Monographien aus dem Gesamtgebiete der Psychiatrie, vol 18. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-88516-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-88516-7_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-88518-1
Online ISBN: 978-3-642-88516-7
eBook Packages: Springer Book Archive